MERCURY has long been used in the treatment of heart failure, but the use of the more complicated organic mercury compounds dates from the introduction of novasurol as a diuretic by Saxl [61 in 1920. Injected either intramuscularly or intravenously in the form of a 10% solution, in doses of e to 2 c.c., novasurol was found to produce a prompt diuresis of 3 to 6 litres in cases of cedema. Further clinical experience soon showed, bowever, that novasurol was liable to induce a severe degree of mercurial poisoning, and such complications as stomatitis, diarrhoea, hamorrhagic colitis, proctitis, nephritis and haematuria, were reported, and fatalities occurred. According to Barker and O'Hare [1] mercurialism of some degree occurs in 25% of cases treated by novasurol. My personal experience with novasurol has been slight, as I abandoned it quickly owing to its toxicity. Salyrgan was introduced later by a German firm, and the first reports on its clinical use as a diuretic appear to be those of Brunn [3] and Bernheim [2] in 1924.
clinical use as a diuretic appear to be those of Brunn [3] and Bernheim [2] in 1924. Salyrgan is a complex organic mercury compound of sodium-salicyl-allyl-amidoacetate, and contains 36% of mercury. Though it contains a slightly higher percentage of mercury than novasurol, it is far less toxic. It is put up for injection in a 10% solution and the dosage is the same as that of novasurol, namelv 2 to 2 c.c.
Pharmacology.-Without discussing in detail the theoretical mode of action of salyrgan and novasurol, it may be said that they are supposed to be "tissue diuretics," acting by diminishing the affinity of the tissue colloids for water and sodium chloride. Crawford and McIntosh [4] found that a dilution of the blood and an increase in chloride concentration -preceded diuresis. The total chloride excreted in the urine is increased, but the urea is little affected. Others believe that salyrgan acts mainly on the kidneys, either directly or as part of a general vascular effect. Clinical experience lends support to this, as salyrgan fails, or is less effective, in pure renal oedema such as we find in nephrosis, and it appears that reasonably efficient renal function is essential for salyrgan diuresis. Both salyrgan and novasurol act better when combined with the administration of acid-producing salts such as ammonium nitrate or chloride, or calcium chloride. Recently Schelling and Tarr [7] have obtained equally good results by combining magnesium sulphate with salyrgan. They inject 15 c.c. of 50% magnesium sulphate with 2 c.c. of salyrgan and a small quantity of novocain deeply into the buttock. I have no experience with this method but I believe that intramuscular injections are best avoided.
It has been assumed that salyrgan has a less powerful diuretic action than novasurol, but this has been questioned by others, for instance by Grunke [5] , and I think that salyrgan is often, though not always, the equal of novasurol and that, under similar conditions, both will prove effective. Toxic effects.-Mercurialism never results from salyrgan in proper doses, as far as my own experience goes. I have never observed it in the course of several hundred injections, and Bernheim, in 1,000 injections, saw no toxic results. Others have had similar experience, and I know of no reported cases of mercurial poisoning from salyrgan. Two of my patients have had over 50 c.c. of salyrgan in eighteen months without ill-effect. For this reason, salyrgan should entirely replace novasurol as a diuretic.
Clinical experience.-Since first observing the excellent results of salyrgan in cardiac failure eighteen months ago, in Vienna, I have employed it regularly and with increasing success as I gained experience with it. After a trial of intramuscular injections, given without any special regimen of fluid restriction, I found the intravenous method far superior in every way. Not only is the diuretic effect more powerful and more certain, but the unpleasant and painful complications which often follow gluteal injections are avoided. I give a first dose of 1 c.c., and then 2 c.c. doses at intervals of four days for as long as is required. The salyrgan solution should be diluted to 10 c.c. with sterile distilled water or saline, and all alcohol should be removed from the syringe. The injection should be given very slowly, taking several minutes altogether, and, after removing the needle from the vein, the arm should be-elevated above heart level at once, so as to empty the vein. Given in this way I have not had a thrombosis of the vein, but if given undiluted, thrombosis is not uncommon. In one case thrombosis of the radial artery occurred, and I think that undiluted salyrgan must have leaked from the vein, around the wall of the artery, as the pulse only disappeared after several days.
In the treatment of severe cardiac failure by salyrgan, the following routine has proved best:
(1) Give salyrgan intravenously; first dose 1 c.c., followed by 2 c.c. doses at intervals of four days.
(2) Give ammonium chloride by mouth in doses of 15 to 30 gr. thrice dagily.
(3) Routine digitalis treatment should not be modified and full digitalization should be rapidly induced and maintained.
(4) Fluid restriction must be rigid. Usually the total fluid intake should be reduced to 20 to 30 oz. in twenty-four hours, and should never exceed 35 oz. I believe fluid restriction is the key to successful treatment by dehydration with salyrgan.
(5) If hydrothorax is present-and a unilateral right-sided hydrothorax is almost the rule in cases of gross heart failure requiring salyrgan-paracentesis should be performed, not more than 35 to 40 oz. being removed slowly at a single operation. It is not necessary to tap ascites.
(6) The patient should be weighed daily, as body weight is the best guide in judging the progress of dehydration treatment. Ambulatory cases are easily weighed, and any rapid gain in weight indicates fluid retention at once. Used in this way, there is almost always a prompt diuresis of 100 to 200 oz. after the first doses, and a fall in weight of 14 to 20 lb. in the first week, and up to 40 to 50 lb. in a few weeks. The diuresis begins in one to two hours and may last forty-eight hours, but it is usually over in twenty-four hours.
Contra-indications.-Acute nephritis, or the presence of blood in the urine, must, at present, be regarded as an absolute contradiction to salyrgan. Albuminuria is no contradiction. Perhaps diarrhoea or colitis should entail caution. It has been stated that salyrgan predisposes to thrombosis, and therefore the presence of thrombosis anywhere should also entail caution.
Type of case.-I have records of my results from salyrgan in twenty-seven cases of cardiac failure of different types, as follows: rheumatic heart disease, eleven cases; hypertensive heart disease, seven cases; syphilitic heart disease, five cases; adherent pericardium (Pick's disease type), two cases; auricular flutter of undetermined origin, one case.
In only three of these cases did I fail to get satisfactory diuresis, and in all three the patients were moribund before receiving salyrgan.
It is not necessary to have cedema to obtain benefit from salyrgan dehydration, as fluid retention of several litres, or 10 to 12 lb. increase of body weight, may occur without cedema. If the liver is large, the lungs engorged, and the cervical veins filled abnormally, benefit may be obtained. Salyrgan has one advantage over digitalis: it acts equally well in failure with normal rhythm as in failure with fibrillation. In syphilitic heart failure, salyrgan should be, theoretically, the ideal drug, as it combats not only the failure but also its underlying cause. Though I have had good immediate results from salyrgan, the prognosis in syphilitic failure is so grave that lasting benefit is scarcely to be expected. Salyrgan cannot restore a damaged heart, but it can give to a patient with chronic failure great amelioration and, if diuretics are of any value at all, then it is unquestionably the best we possess at present, and should be the first choice.
Illustrative 433 claudication, enlarged heart, and aortic incompetence; blood-pressure, 210/100 mm. Wassermann reaction, positive. Admitted to hospital with congestive failure and cedema; taking digitalis. Treatment by salyrgan and fluid restriction produced diuresis up to 180 oz. in twenty-four hours, and fall in body weight of 20 lb. in two weeks. Great improvement but failure recurred later, and further salyrgan again removed cedema. (See fig. 3.) Case IV.-Chronic adherent pericardium with calcification (Pick's disease). Male, aged 36. Liver and spleen enlarged for many years, and calcification of pericardium discovered by X-ray examination. In bed two months with cedema of legs, thighs and back, and ascites; taking digitalis. Female, aged 40. Rheumatic fever when aged 3. Breathless for, many years, and for three months unable to get about owing to dyspnaea and cedema; deep cyanosis, liver enlarged and pulsating forcibly, jugular veins greatly distended and pulsating. Digitalis had already been given and was continued. Salyrgan injections and fluid restriction gave a prompt diuresis, and a loss of body weight of 38 lb. in four weeks. Improvement was great, andOthe patient has now been getting about, free from gross failure, -for eighteen months. Salyrgan injections have been given at weekly or fortnightly intervals, and if they are stopped the oedema reappears. In all, 75 c.c. of salyrgan given without any toxic effect. (See fig. 5 Summary.-Salyrgan may prove useful under the following conditions (1) In gross congestive failure of recent onset, as anl adjunct to digitalis it hastens recovery.
(2) In cases of chronic failure, when hepatic enlargement and cedema persist in spite of full digitalization, it will often banish cedema and add greatly to the comfort and efficiency of the patient. Weekly or fortnightly doses may be given to ambulatory cases, and should aim at keeping an optimum body weight.
(3) In cases of adherent pericardium with ascites, or of pericardial effusion with cedema of superior vena caval distribution.
[The paper was discussed by Dr. Strickland Goodall, Sir James Dundas-Grant, Dr. F. E. Loewy, Dr. Terence East and Dr. H. Gainsborough.] REFERENCES.
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